GILD241227C102000
- 0.23
- 0.000.00%
Gilead Sciences Newsroom
Gilead Sciences (GILD) Made Big Announcements in Q3
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold?
Gilead Sciences to Present at Upcoming Investor Conference
Friday Opens With Falling Prices, but Market Turns Around | Live Stock
19% Of This Gilead Sciences Insider's Holdings Were Sold
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
(GILD) - Analyzing Gilead Sciences's Short Interest
Gilead Raises Assembly Bio Stake to ~30%
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding
Press Release: Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding From Gilead to Advance Clinical Development Programs
Tesla, Bitcoin, S&P 500, Dow, Tank: Thanks a Lot FOMC | Wall Street Today
Express News | FOMC Cuts Interest Rates by 25 Basis Points, Sees Fewer Reductions Next Year
Dow Breaks Downward Spiral, with FOMC Rate Cut on Deck | Live Stock
GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer
Tuesday, Tech Pulls Back, While Traders Await FOMC Rate | Wall Street Today
Tuesday Tech Pull Back After Nasdaq and Bitcoin Record | Live Stock
Gilead Gets FDA Breakthrough Therapy Status for Trodelvy